Home

Render придружавам единствено ioannis tarnanas altoida край През готвя ястие

Altoida secures funding and research partnership with Eisai Innovation –  Venturelab
Altoida secures funding and research partnership with Eisai Innovation – Venturelab

Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum

Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award |  ellines.com
Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com

Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED

Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum

New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status -  Being Patient
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient

Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference

Using augmented reality, Altoida is identifying the likely onset of  neurodegenerative diseases | TechCrunch
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch

Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using  Augmented Reality on your iPhone | Startup Ranking
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking

Ioannis Tarnanas's email & phone | Altoida's Founder email
Ioannis Tarnanas's email & phone | Altoida's Founder email

New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status -  Being Patient
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient

Using augmented reality, Altoida is identifying the likely onset of  neurodegenerative diseases | TechCrunch
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch

Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni

EIT Health - Congratulations to Altoida for raising $6.3M Series A to  Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine  Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the

Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease

Ioannis Tarnanas | Nature Portfolio Health Community
Ioannis Tarnanas | Nature Portfolio Health Community

Greek Researcher Receives Top European Innovation Award (video)
Greek Researcher Receives Top European Innovation Award (video)

Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute

Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute

Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni

Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida

A brain fitbit that can spot Alzheimer's with up to 94% accuracy
A brain fitbit that can spot Alzheimer's with up to 94% accuracy

Using a Digital Neuro Signature to measure longitudinal individual-level  change in Alzheimer's disease: the Altoida large cohort study | npj Digital  Medicine
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine

Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida